FDA Approved: NEOSTIGMINE METHYLSULFATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Neostigmine methylsulfate submitted by Fresenius Kabi USA, LLC. The approval updates the product’s labeling and allo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Neostigmine Methylsulfate (neostigmine methylsulfate)

Snippet

SUPPL AP for NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)